Diagnosis and management of al amyloidosis due to b-cell non-hodgkin lymphoma

HIGHLIGHTS

• who: Callie Berkowitz from the University Medical Center Utrecht, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States have published the research work: Diagnosis and management of AL amyloidosis due to B-cell non-Hodgkin lymphoma, in the Journal: (JOURNAL)
• what: The overall goal of treatment is to eliminate the production of amyloid protein by targeting the underlying B-cell NHL.
• how: Monoclonal gammopathy of neurologic significance (MGNS) may be diagnosed if the following factors are present symmetric sensory deficits slow progression length WM) (74%) . The authors declare that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.